Phase II Trial of Temsirolimus in Patients with Relapsed or Refractory Multiple Myeloma

Por Farag, Sherif S., Zhang, Shuhong, Jansak, Buffy S., Wang, Xiaojing, Kraut, Eric, Chan, Kenneth, Dancey, Janet E., Grever, Michael R.
Publicado em 2009

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment

Por Taube, Sheila E., Clark, Gary M., Dancey, Janet E., McShane, Lisa M., Sigman, Caroline C., Gutman, Steven I.
Publicado em 2009

Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway

Por Busaidy, Naifa L., Farooki, Azeez, Dowlati, Afshin, Perentesis, John P., Dancey, Janet E., Doyle, Laurence A., Brell, Joanna M., Siu, Lillian L.
Publicado em 2012

Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study

Por Jakacki, Regina I., Hamilton, Marta, Gilbertson, Richard J., Blaney, Susan M., Tersak, Jean, Krailo, Mark D., Ingle, Ashish M., Voss, Stephan D., Dancey, Janet E., Adamson, Peter C.
Publicado em 2008

The Globalization of Cooperative Groups

Por Valdivieso, Manuel, Corn, Benjamin W., Dancey, Janet E., Wickerham, D. Lawrence, Horvath, L. Elise, Perez, Edith A., Urton, Alison, Cronin, Walter M., Field, Erica, Lackey, Evonne, Blanke, Charles D.
Publicado no Semin Oncol (2015)

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Por Choong, Nicholas W., Mauer, Ann M., Haraf, Daniel J., Lester, Eric, Hoffman, Philip C., Kozloff, Mark, Lin, Shang, Dancey, Janet E., Szeto, Livia, Grushko, Tatyana, Olopade, Olufunmilayo I., Salgia, Ravi, Vokes, Everett E.
Publicado no J Thorac Oncol (2008)

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Por Oza, Amit M., Elit, Laurie, Tsao, Ming-Sound, Kamel-Reid, Suzanne, Biagi, Jim, Provencher, Diane Michele, Gotlieb, Walter H., Hoskins, Paul J., Ghatage, Prafull, Tonkin, Katia S., Mackay, Helen J., Mazurka, John, Sederias, Joana, Ivy, Percy, Dancey, Janet E., Eisenhauer, Elizabeth A.
Publicado em 2011

A Phase II Study of Erlotinib and Bevacizumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Por Cohen, Ezra EW, Davis, Darren W., Karrison, Theodore G, Seiwert, Tanguy Y., Wong, Stuart J., Nattam, Sreenivasa, Kozloff, Mark F., Clark, Joseph I., Yan, Duen-Hwa, Liu, Wen, Pierce, Carolyn, Dancey, Janet E, Stenson, Kerstin, Blair, Elizabeth, Dekker, Allison, Vokes, Everett E
Publicado em 2009

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Por de Souza, Jonas A., Davis, Darren W., Zhang, Yujian, Khattri, Arun, Seiwert, Tanguy Y., Aktolga, Serdal, Wong, Stuart J., Kozloff, Mark F., Nattam, Sreenivasa, Lingen, Mark W., Kunnavakkam, Rangesh, Stenson, Kerstin, Blair, Elizabeth A., Bozeman, Jeffrey, Dancey, Janet E., Vokes, Everett E., Cohen, Ezra E. W.
Publicado no Clin Cancer Res (2012)

Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma

Por Davies, Michael A., Fox, Patricia S., Papadopoulos, Nicholas E., Bedikian, Agop Y., Hwu, Wen-Jen, Lazar, Alexander J. F., Prieto, Victor G., Culotta, Kirk S., Madden, Timothy L., Xu, Quanyun, Huang, Sha, Deng, Wanleng, Ng, Chaan, Gupta, Sanjay, Liu, Wenbin, Dancey, Janet E., Wright, John J., Bassett, Roland L., Hwu, Patrick, Kim, Kevin B.
Publicado em 2012

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

Por Lee, Eudocia Q., Kuhn, John, Lamborn, Kathleen R., Abrey, Lauren, DeAngelis, Lisa M., Lieberman, Frank, Robins, H. Ian, Chang, Susan M., Yung, W. K. Alfred, Drappatz, Jan, Mehta, Minesh P., Levin, Victor A., Aldape, Kenneth, Dancey, Janet E., Wright, John J., Prados, Michael D., Cloughesy, Timothy F., Gilbert, Mark R., Wen, Patrick Y.
Publicado em 2012